Contract facts
UnrestrictedNo full NAICS 621511 intel page yet. Browse NAICS intelligence
SYNTHESIS SERVICES FOR CUSTOM BIOMOLECULES (GENE CONSTRUCTS AND PEPTIDES) IN SUPPORT OF NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), CENTER FOR CANCER RESEARCH (CCR), SURGERY BRANCH (SB) is a federal Unrestricted award for Nih Nci held by Genscript Usa Inc. Estimated value $3.1M ($2.1M obligated). Current period of performance ends Sep 23, 2026 (potential Sep 23, 2027). Last award drew 2 bidders. Place of performance: PISCATAWAY NJ. Related solicitation 75N91024Q00094.
SYNTHESIS SERVICES FOR CUSTOM BIOMOLECULES (GENE CONSTRUCTS AND PEPTIDES) IN SUPPORT OF NATIONAL INSTITUTES OF HEALTH (NIH), NATIONAL CANCER INSTITUTE (NCI), CENTER FOR CANCER RESEARCH (CCR), SURGERY BRANCH (SB)
Recompete timing
PublicCurrent PoP ended Sep 23, 2026 (4 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on 75N91024P00630? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordGenscript Usa Inc — $5.5M obligated across 101 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N91024P00630?
75N91024P00630 (NIH NCI services) is a Nih Nci award with a potential value of $3.1M, currently held by Genscript Usa Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N91024P00630?
Nih Nci awarded 75N91024P00630 to Genscript Usa Inc (potential $3.1M).
Who is the incumbent on 75N91024P00630?
Genscript Usa Inc is the incumbent with $5.5M across 101 related awards in SCOUT’s public footprint. The current period of performance ends Sep 23, 2026.
When does Genscript Usa Inc’s 75N91024P00630 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 23, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N91024P00630? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.